This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14:453–501.
Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96:245–254.
Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999; 59:1701s–1706s.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basis biological phenomen with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239–257.
Häcker G. The morphology of apoptosis Cell Tiss Res 2000; 301:5–17.
Shi Y. Mechanisms of caspases activation and inhibition during apoptotsis. Mol Cell 2002; 9:459–470.
Majino G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3–15.
Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7:663–698.
Levi-Montalcini, R. The nerve growth factor 35 years later. Science 1987; 237:1154–1162.
Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 1987; 109:145–178.
Landmesser L, Pilar G. Interactions between neurons and their targets during in vivo synaptogenesis. Fed Proc 1987; 37:2016–2022.
Landmesser L. The relationship of intermuscular nerve branching and synaptogenesis to motoneuron survival. J Neurobiol 1992; 23:1131–1139.
Sohal GS. The role of target size in neuronal survival. J Neurobiol 1992; 23:1124–1130.
Hollyday M, Hamburger V. Reduction of the naturally occurring motor neuron loss by enlargement of the periphery. J Comp Neurol 1976; 170:311 320.
Pettmann B, Henderson CE. Neuron cell death. Neuron 1998; 20:633–647.
De la Rosa EJ, de Pablo F. Cell death in early neural development: beyond the neurotrophic theory. TINS 2000; 23:454–457.
Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nature Genetics 2001; 28:113–118.
Kuida K, Zheng TS, Na TQ et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384:368–372.
Kuida K, Haydar TF, Kuan CY et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94:325–337.
Cecconi F, Gruss P. Apaf1 in developmental apoptosis and cancer: how many ways to die. CMLS 2001; 58:1688–1697.
Glückmann A. Cell death in normal vertebrate ontogeny. Biol Rev 1951; 26:59–86.
Jacobson MD, Weil M, Raff M. Programmed cell death in animal development. Cell 1997; 88:347–54.
Barres BA, Hart IK, Coles HS et al. Cell death and control of survival in the oligodendrocyte lineage. Cell 1992; 70:31–46.
Grinspan JB, Marchionni MA, Reeves M et al. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 1996; 16:6107–6118.
Trachtenberg JT, Thompson WJ. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 1996; 379:174–177.
Gu C, Casaccia-Bonnefil P, Srinivasan A et al. Oligodendrocyte apoptosis mediated by caspases activation. J Neurosci 1999; 19:3043–3049.
Winseck AK, Caldero J, Ciutat D et al. In Vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor. J Neurosci 2002; 22:4509–4521.
Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941–1953.
Sulston JE, Schierenberg E, White JG et al. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 1983; 100:64–119.
Metzstein MM, Stanfield GM, Horvitz HR. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 1998; 14:410–416.
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312–1316.
Nicholson DW, Thornberry NA. Caspases—killer proteases. Trends Biochem.. Sci. 1997; 22:299–306.
Hofmann K, Bucher P, Tschopp J. The CARD domain—a new apoptotic signaling motif. Trends Biochem Sci 1997; 22:155–156.
Chou JJ, Matsuo H, Duan H, Wagner R. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 1998; 94:171–180.
Adams JM, Cory S. The bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322–1326.
Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13:1899–1911.
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivowith a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609–619.
Nguyen M, Millar DG, Yong VW et al. Targeting of Bcl-2 to mitochondrial outer membrane by COOH-terminal signal sequence. J Biol Chem 1993; 268:25265–25268.
Hockenberry D, Nunez G, Milliman C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334–336.
Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 1997; 94:3668–3672.
Gross A, Jockel J, Wei MC et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17:3878–3885.
Liu X, Kim CN, Yang J et al. Induction of apoptotic program in cell-free extreacts: requirement for dATP and cytochrome c. Cell 1996; 86:147–157.
Kluck RM, Bossy-Wetzel E, Green DR et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275:1132–1136.
Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspases activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17:37–49.
Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspases-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479–489.
Zou H, Henzel WJ, Liu X et al. Apaf-1, a human homolog to C. elegans CED-4 participates in cyrochrome c-dependent activation of caspases-3. Cell 1997; 90:405–413.
Sanna MG, da Silva Correia J, Ducrey O et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspases inhibition. Mol Cell Biol 2002; 22:1754–1766.
Roy N, Mahadevan MS, McLean M et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80:167–178.
Shin S, Sung BJ, Cho YS et al. An apoptotic protein human surviving is a direct inhibitor of caspases-3 and caspases-7. Biochemistry 2001; 40:1117–1123.
Tamm I, Wang Y, Sausville DA et al. IAP-family protein surviving inhibits caspases activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58:5315–5320.
Wienseck AK, Caldero J, Ciutat D et al. In vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor. J Neurosci 2002; 22:4509–4521.
McCarthy NJ, Whyte MK, Gilbert CS, et al. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 1997; 136:215–227.
Joza N, Susin SA, Daugas E et al. Essential role of mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410:549–554.
Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305–1308.
Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76:959–962.
Gruss HJ, Dower SK. Tumor necrosis factor logand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85:3378–3404.
Tartaglia LA, Ayres TM, Wong GH et al. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74:845–853.
Nagata S. Apoptosis by death factor. Cell 1997; 88:355–365.
Huang B, Eberstadt M, Olejniczak ET et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996; 384:638–641.
Boldin MP, Goncharov TM, Goltsev YV et al. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996; 85:803–815.
Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85:817–827.
Muzio M, Stockwell BR, Stennicke HR et al. An induced proximity model for caspases-8 activation. J Biol Chem 1998; 273:2926–2930.
Liepinsh E, Ilag LI, Otting G et al. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J 1997; 16:4999–5005.
Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383:166–168.
Naumann T, Casademunt E, Hollerbach E et al. Complete deletion of the neurtrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci 2002; 22:2409–2418.
Miller FD, Kaplan DR. Neurotrophin signaling pathways regulating neuronal apoptosis. CMLS 2001; 58:1045–1053.
Chao MV, Bothwell M. Neurotrophins: to cleave or not to cleave. Neuron 2002; 33:9–12.
Casademunt E, Carter BD, Benzel I et al. The zinc finger protein NRIF interacts with the neurotrophin receptor p75NTR and participates in programmed cell death. EMBO J 1999; 21:6050–6061.
Frade JM, Barde YA. Genetic evidence for cell deathmediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999; 126:683–690.
Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 1997; 124:2203–2212.
Graham A, Koentges G, Lumsden A. Neural crest apoptosis and the establishment of craniofacial pattern: an honorable death. Mol Cell Neurosci 1996; 8:76–83.
Krieglstein K, Richter S, Farkas L et al. Reduction of endogenous transforming growth factor beta prevents ontogenetic neuron death. Nature Neuroscience 2000; 3:1085–1091.
Dünker N, Schuster N, Krieglstein K. Transforming Growth Factor Beta Modulates Programmed Cell Death in the Retina of the Developing Chick Embryo. Development 2001; 128:1933–1942.
Parkinson DB, Dong Z, Bunting H et al. Transforming growth factor β (TGF-β) mediates Schwann cell death in vitro and in vivo: examination of c-jun activation, interactions with survival signals, and the relationship of TGF-β-mediated death to Schwann cell differentiation. J Neurosci 2001; 21:8572–8585.
Yu C, Takeda M, Soliven B. Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage. J Neuroimmunol 2000; 108:2–10.
Schuster N, Bender H, Philippi A et al. TGF-β induces cell death in the oligodendroglial cell line OLI-neu. Glia 2002; 40:95–108.
Schuster N, Bender H, Roessler O et al. TGF-β and TNF-α cooperate to induce apoptosis in the oligodendroglial cell line OLI-neu. J Neurosci Res 2003; 73(3):324–33.
Hagimoto N, Kuwano K, Inoshima I et al. TGF-β1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 2002; 168:6470–6478.
Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 2002; 307:1–14.
Honig LS, Rosenberg RN. Apoptosis and neurologic disease. Am J Med 2000; 108:317–330.
Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tiss Res 2000; 301:173–187.
Springer JE, Nottingham SE, McEwen ML et al. Caspase-3 apoptotic signaling following injury to the central nervous system. Clin Chem Lab Med 2001; 39:299–307.
Dikranian K, Ishimaru MJ, Tenkova T et al. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis 2001; 8:359–379.
Jellinger KA. Cell death mechanisms in neurodegeneration. J Cell Mol Med 2001; 5:1–17.
Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45:421–429.
Kugler S, Straten G, Kreppel F. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 2000; 7:815–824.
Pender MP, Rist MJ. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 2001; 36:137–144.
Zipp F, Krammer PH, Weller M. Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. Immunol Today 1999; 20:550–554.
Higami Y, Shimokawa I. Apoptosis in the aging process. Cell Tiss Res 2000; 301:125–132.
Motoyama N, Wang F, Roth KA et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267:1506–1510.
Knudson CM, Tung KS, Tourtellotte WG et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270:96–99.
Lindsten T, Ross Aj, King A et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissue. Mol Cell 2000; 6:1389–1399.
Cecconi F, Alvarezbolado G, Meyer BI et al. Apaf1 (Ced-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94:727–737.
Yoshida H, Kong YY, Yoshida R et al. Apaf1 is required for mitochondrial pathways of apoptosis and barin development. Cell 1998; 94:739–750.
Honarpour N, Du C, Richardson JA et al. Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 2000; 218:248–258.
Hakem R, Hakem A, Duncan GS et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94:339–352.
Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17:3261–3270.
Brojatsch J, Naughton J, Rolls MM. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leucosis-sarcoma viruses and mediates apoptosis. Cell 1996; 87:845–855.
Chinnaiyan AM, O’Rourke K, Yu GL et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274:990–992.
Kitson J, Raven T, Jiang YP et al. A death-domain-containing receptor that mediates apoptosis. Nature 1996; 384:371–375.
Chicheportiche Y, Bourdon PR, Xu H et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997; 272:32401–32410.
Marsters SA, Sheridan JP, Pitti RM et al. Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 1998; 8:525–528.
Pan G, Ni J, Wei YF et al. An antagonist decoy receptor and a death domain-containg receptor for TRAIL. Science 1997; 277:815–818.
Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673–682.
Pitti RM, Marsters SA, Ruppert S et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687–12690.
Marsters SA, Pitti RM, Donahue CJ et al. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 1996; 6:750–752.
Pan G, O’Rourke K, Chinnaiyan AM. The receptor for the cytotoxic ligand TRAIL. Science 1997; 276,111–113.
Sheridan JP, Marsters SA, Pitti RM et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277:818–821.
Walczak H, Degli-Esposti MA, Johnson RS et al. TRAIL-Ra: a novel apoptosis-mediating receptor for TRAIL. EMBO J 1997; 16:5386–5397.
Wu GS, Burns TF, McDonald ER III et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997; 17:141–143.
Chaudhary PM, Eby M, Jasmin A et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Innumity 1997; 7:821–830.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Eurekah.com and Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Krieglstein, K. (2006). Cell Death in the Nervous System. In: Bähr, M. (eds) Brain Repair. Advances in Experimental Medicine and Biology, vol 557. Springer, Boston, MA. https://doi.org/10.1007/0-387-30128-3_1
Download citation
DOI: https://doi.org/10.1007/0-387-30128-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47859-8
Online ISBN: 978-0-387-30128-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)